[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Page 70832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25276]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Deputy Director for Infectious 
Diseases (BSC, DDID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting for the Board of Scientific Counselors, Deputy 
Director for Infectious Diseases (BSC, DDID). This virtual meeting is 
open to the public via Zoom, limited only by the number of web 
conference lines available (500 lines). Pre-registration is required by 
accessing the link below in the addresses section.

DATES: The meeting will be held on December 7, 2022, from 9:00 a.m. to 
5:15 p.m., EST, and December 8, 2022, from 8:30 a.m. to 1:00 p.m., EST.

ADDRESSES: Zoom virtual meeting. Pre-registration is required by 
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_PbAc34lET9uD2RN8lopzig. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Laura Hughes-Baker, Ph.D., Designated 
Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, 
Georgia 30329-4027; Telephone: (404) 639-1402; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The BSC, DDID provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the CDC Deputy Director for Infectious Diseases; and the Directors of 
the National Center for Emerging and Zoonotic Infectious Diseases, the 
National Center for HIV, Viral Hepatitis, STD, and TB Prevention, and 
the National Center for Immunization and Respiratory Diseases, CDC, 
concerning strategies, goals, and priorities for the programs and 
research within the national centers and monitors the overall strategic 
direction and focus of DDID and the national centers.
    Matters to be Considered: The agenda will include updates and 
discussions on recent outbreaks and affected populations, as well as 
brief reports from two of the Board's workgroups: the Food Safety 
Modernization Act Surveillance Working Group and the Acute Flaccid 
Myelitis Task Force. Agenda items are subject to change as priorities 
dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-25276 Filed 11-18-22; 8:45 am]
BILLING CODE 4163-18-P